A detailed history of U.S. Capital Wealth Advisors, LLC transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, U.S. Capital Wealth Advisors, LLC holds 29,714 shares of IDNA stock, worth $628,451. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,714
Previous 25,162 18.09%
Holding current value
$628,451
Previous $515,000 18.25%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 14, 2025

BUY
$17.92 - $21.5 $81,571 - $97,868
4,552 Added 18.09%
29,714 $609,000
Q1 2025

Apr 29, 2025

BUY
$20.49 - $23.63 $124,025 - $143,032
6,053 Added 31.68%
25,162 $515,000
Q4 2024

Jan 24, 2025

BUY
$22.38 - $25.53 $427,659 - $487,852
19,109 New
19,109 $432,000

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.